Defilade Capital Management, L.P.

CIK 0002088557 · EMERYVILLE, CA · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source

Defilade Capital Management, L.P. reported 39 positions worth $746.9M as of June 30, 2026 (13F filed August 14, 2026). Largest holding: LLY (6.3%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$746.9M
2026 Q2
Positions
39
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
46.5%
Est. Net Flow (Q)
2026 Q2
10 / 39 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1LLYELI LILLY & COSH$46.9M6.28%39,086
2PFEPFIZER INCSH$42.7M5.71%1,771,743
3VEEVVEEVA SYS INCSH$42.0M5.62%236,709
4BMRNBIOMARIN PHARMACEUTICAL INCSH$39.0M5.22%682,005
5PTCTPTC THERAPEUTICS INCSH$35.4M4.74%433,699
6BAXBAXTER INTL INCSH$31.1M4.17%1,459,380
7INSMINSMED INCSH$30.0M4.02%281,838
8ZBHZIMMER BIOMET HOLDINGS INCSH$27.3M3.66%317,426
9PODDINSULET CORPSH$26.9M3.61%176,932
10TMOTHERMO FISHER SCIENTIFIC INCSH$26.0M3.49%51,934

The free plan shows the top 10 positions. The remaining 29 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Defilade Capital Management, L.P. hold as of Q2 2026?

Defilade Capital Management, L.P. reported 39 positions worth $746.9M in its Q2 2026 13F filing. Largest positions: LLY (6.3%), PFE (5.7%), VEEV (5.6%), BMRN (5.2%) and PTCT (4.7%).

What did Defilade Capital Management, L.P. buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Defilade Capital Management, L.P. sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.